OBJECTIVES: To investigate the long-term impact of multivessel coronary artery disease (MVD) on cause-specific mortality in patients with ST elevation myocardial infarction (STEMI) treated with reperfusion therapy. METHODS AND RESULTS:Patients with STEMI (n = 395) treated withprimary angioplasty or thrombolysis in the setting of a randomised clinical trial were enrolled in the study. Follow up was 8 (2) years. For patients who died all available records were reviewed to assess the specific cause of death. MVD was present in 57% of patients. Patients with MVD were older and more of them had diabetes and previous myocardial infarction. Compared with the non-MVD group, residual left ventricular ejection fraction was lower (45.9% v 49.6%, p = 0.001) and total mortality was higher in patients with MVD (32% v 19%, p = 0.002). After adjustment for potential confounders this association was not significant (hazard ratio 1.4, 95% confidence interval (CI) 0.9 to 2.2). When the specific cause of death was considered, sudden death was comparable between patients with and without MVD (10% v 8%, p = 0.49) but death caused by heart failure was significantly higher in patients with MVD (hazard ratio 7.4, 95% CI 1.7 to 32.2). CONCLUSION: Patients with STEMI and MVD have a higher long-term mortality than do patients with non-MVD. MVD is not an independent predictor of long-term total mortality or sudden death. However, MVD is a very strong and independent predictor of long-term death caused by heart failure.
RCT Entities:
OBJECTIVES: To investigate the long-term impact of multivessel coronary artery disease (MVD) on cause-specific mortality in patients with ST elevation myocardial infarction (STEMI) treated with reperfusion therapy. METHODS AND RESULTS:Patients with STEMI (n = 395) treated with primary angioplasty or thrombolysis in the setting of a randomised clinical trial were enrolled in the study. Follow up was 8 (2) years. For patients who died all available records were reviewed to assess the specific cause of death. MVD was present in 57% of patients. Patients with MVD were older and more of them had diabetes and previous myocardial infarction. Compared with the non-MVD group, residual left ventricular ejection fraction was lower (45.9% v 49.6%, p = 0.001) and total mortality was higher in patients with MVD (32% v 19%, p = 0.002). After adjustment for potential confounders this association was not significant (hazard ratio 1.4, 95% confidence interval (CI) 0.9 to 2.2). When the specific cause of death was considered, sudden death was comparable between patients with and without MVD (10% v 8%, p = 0.49) but death caused by heart failure was significantly higher in patients with MVD (hazard ratio 7.4, 95% CI 1.7 to 32.2). CONCLUSION:Patients with STEMI and MVD have a higher long-term mortality than do patients with non-MVD. MVD is not an independent predictor of long-term total mortality or sudden death. However, MVD is a very strong and independent predictor of long-term death caused by heart failure.
Authors: R T van Domburg; D P Foley; P J de Feyter; W van der Giessen; M J van den Brand; P W Serruys Journal: Eur Heart J Date: 2001-06 Impact factor: 29.983
Authors: J P Ottervanger; A W van 't Hof; S Reiffers; J C Hoorntje; H Suryapranata; M J de Boer; F Zijlstra Journal: Eur Heart J Date: 2001-05 Impact factor: 29.983
Authors: J K Kahn; B D Rutherford; D R McConahay; W L Johnson; L V Giorgi; T M Shimshak; R Ligon; G O Hartzler Journal: J Am Coll Cardiol Date: 1990-11 Impact factor: 24.094
Authors: F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata Journal: N Engl J Med Date: 1999-11-04 Impact factor: 91.245
Authors: J H O'Keefe; B D Rutherford; D R McConahay; R W Ligon; W L Johnson; L V Giorgi; J E Crockett; B D McCallister; R D Conn; G M Gura Journal: Am J Cardiol Date: 1989-12-01 Impact factor: 2.778
Authors: H D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; J A Ormiston; T Whitlock Journal: N Engl J Med Date: 1987-10-01 Impact factor: 91.245
Authors: F J Neumann; R Blasini; C Schmitt; E Alt; J Dirschinger; M Gawaz; A Kastrati; A Schömig Journal: Circulation Date: 1998-12-15 Impact factor: 29.690
Authors: René J van der Schaaf; Bimmer E Claessen; Loes P Hoebers; Niels J Verouden; Jacques J Koolen; Maarten J Suttorp; Emanuele Barbato; Matthijs Bax; Bradley H Strauss; Göran K Olivecrona; Vegard Tuseth; Dietmar Glogar; Truls Råmunddal; Jan G Tijssen; Jan J Piek; José P S Henriques Journal: Trials Date: 2010-09-21 Impact factor: 2.279
Authors: S Rasoul; V van Ommen; J Vainer; M Ilhan; L Veenstra; R Erdem; L A W Ruiters; R Theunissen; J C A Hoorntje Journal: Neth Heart J Date: 2015-04 Impact factor: 2.380
Authors: Pedro A Villablanca; Wilman Olmedo; Michael Weinreich; Tanush Gupta; Divyanshu Mohananey; Felipe N Albuquerque; Ibrahim Kassas; David Briceño; Cristina Sanina; Thomas A Brevik; Emily Ong; Harish Ramakrishna; Michael Attubato; Mark Menegus; Jose Wiley; Ankur Kalra Journal: J Am Heart Assoc Date: 2018-04-13 Impact factor: 5.501